Coronavirus vaccine effective on autoimmune disease patients, study finds
Patients were selected to participate in the study on the day they received their first vaccine shot and they were invited to come back between two to four weeks after the second dose
Vials with Pfizer-BioNTech and Moderna coronavirus disease (COVID-19) vaccine labels are seen in this illustration picture taken March 19, 2021. (photo credit: REUTERS/DADO RUVIC/ILLUSTRATION/FILE PHOTO)ByROSSELLA TERCATINUpdated:
